TSN is delighted to announce that is now the new home for the Amgen Biotech Experience (ABE) in the UK.
Commenting on this significant development for TSN, Phil said
“I am delighted that EDC and the Amgen Foundation have put their faith in me and TSN to lead ABE UK into the next grant cycle and hopefully beyond. Sharing with and learning from colleagues at sites around the world”
